|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash and cash equivalents provided by operating activities, net of acquisitions | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Restructuring charges | |||||
| Loss on early extinguishment of 2022 Convertible Notes | |||||
| Repayment of 2022 Convertible Notes attributable to the debt discount | |||||
| Gain on termination of operating leases | |||||
| Loss on disposal of fixed assets | |||||
| Gain on strategic investments | |||||
| Impairment of strategic investments | |||||
| (Benefit from) provision for deferred income taxes | |||||
| Amortization of debt discount and issuance costs | |||||
| Accretion of bond discount | |||||
| Unrealized currency translation | |||||
| Changes in assets and liabilities, net of acquisition | |||||
| Accounts receivable | |||||
| Prepaid expenses and other assets | |||||
| Deferred commission expense | |||||
| Right-of-use assets | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Operating lease liabilities | |||||
| Deferred revenue | |||||
| Net cash and cash equivalents provided by operating activities | |||||
| Investing Activities: | |||||
| Purchases of investments | |||||
| Maturities of investments | |||||
| Sale of investments | |||||
| Purchases of property and equipment | |||||
| Capitalization of software development costs | |||||
| Purchases of intangible assets | |||||
| Business acquisitions, net of cash acquired | |||||
| Proceeds from sale of strategic investments | |||||
| Payments for equity method investments | |||||
| Proceeds from net working capital settlement | |||||
| Proceeds from strategic investments | |||||
| Purchases of strategic investments | |||||
| Net cash and cash equivalents provided by (used in) investing activities | |||||
| Financing Activities: | |||||
| Payments for settlement of Warrants related to the 2022 Convertible Notes | |||||
| Payment for settlement of 2022 convertible notes | |||||
| Repayment of 2025 Convertible Notes | |||||
| Employee taxes paid related to the net share settlement of stock-based awards | |||||
| Proceeds related to the issuance of common stock under stock plans | |||||
| Repurchases of common stock | |||||
| Net cash and cash equivalents (used in) provided by financing activities | |||||
| Effect on exchange rate changes on cash and cash equivalents | |||||
| Net increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of year | |||||
| Cash, cash equivalents and restricted cash, end of year | |||||
| Supplemental cash flow disclosure: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Right-of-use assets obtained in exchange for operating lease facilities | |||||
| Right-of-use asset reductions related to operating lease terminations | |||||
| Non-cash investing and financing activities: | |||||
| Capital expenditures incurred but not yet paid | |||||
| Settlement of Capped Call Options related to the 2025 Convertible Notes | |||||
| Asset retirement obligations | |||||
| Issuance of common stock for repayment of 2022 Convertible Notes |
Loading...